Search Results - "Braun, Maurine"
-
1
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Published in Circulation (New York, N.Y.) (17-01-2023)“…VERVE-101 is an investigational in vivo CRISPR base-editing medicine designed to alter a single DNA base in the gene, permanently turn off hepatic protein…”
Get full text
Journal Article -
2
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Published in Nature (London) (20-05-2021)“…Gene-editing technologies, which include the CRISPR–Cas nucleases 1 – 3 and CRISPR base editors 4 , 5 , have the potential to permanently modify…”
Get full text
Journal Article -
3
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
Published in Nature communications (08-02-2021)“…A large G 4 C 2 -repeat expansion in C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)…”
Get full text
Journal Article -
4
Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis
Published in Experimental neurology (01-01-2019)“…Current understanding of the pathogenesis of the familial form of amyotrophic lateral sclerosis has been aided by the study of transgenic mice that…”
Get full text
Journal Article -
5
Kinematics of reaching and implications for handedness in rhesus monkey infants
Published in Developmental psychobiology (01-05-2012)“…Kinematic studies of reaching in human infants using two‐dimensional (2‐D) and three‐dimensional (3‐D) recordings have complemented behavioral studies of…”
Get full text
Journal Article -
6
Abstract 11274: VERVE-101—An Investigational Single-Course Gene Editing Medicine Targeting PCSK9—Durably and Potently Lowers PCSK9 and LDL-C Concentrations in Non-Human Primates
Published in Circulation (New York, N.Y.) (08-11-2022)“…IntroductionVERVE-101 is an in vivo CRISPR base editing therapy designed to alter a single DNA base in the PCSK9 gene, permanently inactivate hepatic…”
Get full text
Journal Article -
7
An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves precise and durable liver editing in nonclinical studies
Published in Atherosclerosis (01-08-2024)Get full text
Journal Article -
8
Long-term hematopoietic stem cell gene therapy corrects neuromuscular manifestations in preclinical study of Pompe mice
Published in Molecular genetics and metabolism (01-02-2021)Get full text
Journal Article -
9
Sa1465 - The Pharmacological Properties of APOC3 Antisense Oligonucleotides are Enhanced by Control of Stereochemistry
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2018)Get full text
Journal Article